Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(33.3%)

Phase 3

2(33.3%)

Phase 2

1(16.7%)

Phase 4

1(16.7%)

6Total

N/A(2)

Phase 3(2)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03785106Phase 3Active Not Recruiting

Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals

Role: collaborator

NCT03731559Phase 2Recruiting

Efficacy, Safety and Pharmacokinetics of DTG with RIF

Role: collaborator

NCT06254456Not ApplicableNot Yet Recruiting

Fluid Responsiveness in Prone Patients

Role: lead

NCT03954912Not ApplicableCompleted

Comparative Outcomes Between Image-based Versus Imageless Robot-assisted Unicondylar Knee Arthroplasty

Role: collaborator

NCT02036164Phase 3Unknown

Adjuvant Chemotherapy for Locally Advanced Cervical Cancer

Role: collaborator

NCT01509118Unknown

Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery

Role: collaborator

NCT01344213Phase 4Completed

Pregabalin, Celecoxib, Total Knee Arthroplasty and Intrathecal Morphine

Role: collaborator

All 7 trials loaded